hydralazine has been researched along with Carcinoma, Renal Cell in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis." | 7.72 | P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003) |
| "Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis." | 3.72 | P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norris, JH | 1 |
| Leeds, J | 1 |
| Jeffrey, RF | 1 |
| Knowles, HJ | 1 |
| Tian, YM | 1 |
| Mole, DR | 1 |
| Harris, AL | 1 |
2 other studies available for hydralazine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Carcinoma, Renal Cell; Humans; Hydr | 2003 |
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Topics: Adrenomedullin; Angiogenesis Inducing Agents; Animals; Breast Neoplasms; Carcinoma; Carcinoma, Renal | 2004 |